Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
作者信息
Jung Young Kul, Kim Ju Hyun
出版信息
Clin Mol Hepatol. 2013 Mar;19(1):26-8. doi: 10.3350/cmh.2013.19.1.26. Epub 2013 Mar 25.
Abstract
摘要
相似文献
1
Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
Clin Mol Hepatol. 2013 Mar;19(1):26-8. doi: 10.3350/cmh.2013.19.1.26. Epub 2013 Mar 25.
2
[Comparison of efficacy of peginterferon and ribavirin combination therapy for chronic hepatitis C among Korean, Caucasian and other Asians].
Korean J Gastroenterol. 2012 Nov;60(5):273-4. doi: 10.4166/kjg.2012.60.5.273.
3
[Effect of peginterferon alpha-2a combinated with ribavirin in the treatment of rebound patient with chronic hepatitis C: a case report].
Zhonghua Gan Zang Bing Za Zhi. 2010 Oct;18(10):794. doi: 10.3760/cma.j.issn.1007-3418.2010.10.019.
4
Peginterferon and ribavirin for hepatitis C.
N Engl J Med. 2007 Mar 22;356(12):1270-1; author reply 1271.
5
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
J Hepatol. 2008 Aug;49(2):157-9. doi: 10.1016/j.jhep.2008.05.004. Epub 2008 May 22.
6
Peginterferon and ribavirin for hepatitis C.
N Engl J Med. 2007 Mar 22;356(12):1269; author reply 1271. doi: 10.1056/NEJMc063729.
7
Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
Clin Mol Hepatol. 2015 Jun;21(2):122-4. doi: 10.3350/cmh.2015.21.2.122. Epub 2015 Jun 26.
8
Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
N Engl J Med. 2004 Nov 25;351(22):2340-2; author reply 2340-2. doi: 10.1056/NEJM200411253512220.
9
Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients.
Clin Mol Hepatol. 2012 Sep;18(3):268-71. doi: 10.3350/cmh.2012.18.3.268. Epub 2012 Sep 25.
10
Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
N Engl J Med. 2004 Nov 25;351(22):2340-2; author reply 2340-2.
引用本文的文献
1
Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C.
PLoS One. 2017 Jun 14;12(6):e0179094. doi: 10.1371/journal.pone.0179094. eCollection 2017.
2
Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era.
Gut Liver. 2017 Jul 15;11(4):543-550. doi: 10.5009/gnl16530.
3
No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients.
Clin Mol Hepatol. 2014 Jun;20(2):177-84. doi: 10.3350/cmh.2014.20.2.177. Epub 2014 Jun 30.
本文引用的文献
1
High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice.
Clin Mol Hepatol. 2013 Mar;19(1):60-9. doi: 10.3350/cmh.2013.19.1.60. Epub 2013 Mar 25.
2
Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans.
J Clin Gastroenterol. 2013 Aug;47(7):644-50. doi: 10.1097/MCG.0b013e3182896abf.
3
A nationwide seroepidemiology of hepatitis C virus infection in South Korea.
Liver Int. 2013 Apr;33(4):586-94. doi: 10.1111/liv.12108. Epub 2013 Jan 29.
4
Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C.
Clin Mol Hepatol. 2012 Dec;18(4):360-7. doi: 10.3350/cmh.2012.18.4.360. Epub 2012 Dec 21.
5
[Efficacy of peginterferon and ribavirin combination therapy of chronic hepatitis C: a pooled analysis].
Korean J Gastroenterol. 2012 Nov;60(5):306-14. doi: 10.4166/kjg.2012.60.5.306.
6
IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population.
PLoS One. 2012;7(5):e37054. doi: 10.1371/journal.pone.0037054. Epub 2012 May 23.
7
Efficacy and tolerability of peginterferon alpha plus ribavirin in the routine daily treatment of chronic hepatitis C patients in Korea: a multi-center, retrospective observational study.
Gut Liver. 2012 Jan;6(1):98-106. doi: 10.5009/gnl.2012.6.1.98. Epub 2012 Jan 12.
8
Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin.
J Clin Virol. 2011 Dec;52(4):363-6. doi: 10.1016/j.jcv.2011.08.006. Epub 2011 Sep 9.
9
The Effects of IL-28B and ITPA polymorphisms on treatment of hepatitis C virus genotype 6.
Am J Gastroenterol. 2011 May;106(5):1007-8. doi: 10.1038/ajg.2011.40.
10
EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
J Hepatol. 2011 Aug;55(2):245-64. doi: 10.1016/j.jhep.2011.02.023. Epub 2011 Mar 1.
Zotero 插件